Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.
Great Canadian Gaming Corp. (GC-T) reported revenues of $357.4-million in the fourth quarter, an increase of 8 per cent when compared to the same period in the prior year. Analysts were expecting revenue of $333.4-million.
Net earnings from continuing operations of $45.8-million or 79 cents per share in the fourth quarter compared to earnings of $27.4-million or 44 cents a year earlier.
The Toronto-based construction firm will pay 16 cents per share on April 2, up from 14.5 per cent previously.
Aecon says it earned $20.2 million or 31 cents per diluted share for the three months ended Dec. 31, compared with $27.9 million or 41 cents per share a year earlier.
Revenues decreased 3.3 per cent to $917.3 million.
The company was expected earn 32 cents per share on $934.6 million in revenues, according to financial markets data firm Refinitiv.
-The Canadian Press
Organigram Holdings Inc. (OGI-Q; OGI-T) the parent company of Organigram Inc., says Paolo De Luca, the company’s current chief financial officer has been appointed chief strategy officer and board member Derrick West is joining as CFO.
Paramount Resources Ltd. (POU-T) reported a net loss of $31.1-million or 24 cents per share versus a loss of $170.5-million a year earlier. Adjusted funds flow was $93.5-million or 71 cents versus $45.5-million or 35 cents a year earlier.
Sales were $259.9-million versus $207.4-million a year earlier. Analysts were expecting sales of $240.3-million.
Net income was $1.4-million versus $19.7-million a year ago. Funds from operations were $11.1-million or 14 cents per unit versus $8.9-million or 14 cents a year ago. Adjusted FFO was 13 cents versus 14 cents a year ago, which was in line with expectations.
Clarke Inc. (CKI-T) reported net income of $6-million in the fourth quarter compared to a net loss of $9.8-million in the same period in 2018, “largely driven by the realized and unrealized net gains on investments during the period compared to the same period in the prior year.”
Comprehensive income attributable to equity holders of the company for the fourth quarter was $11.2-million or 36 cents per share compared to a comprehensive loss of $12.2-million or 79 cents for the same period in 2018.
Diluted EPS was 34 cents, compared to a loss of 79 cents for the same period in 2018.
Profound Medical Corp. (PROF-Q; PRN-T) recorded a net loss of $5.1-million or 43 cents per share, compared to a net loss of $4.9-million or 45 cents per share for the same period a year earlier. Analysts were expecting a loss of 65 cents per share.
Sales were $445.9-million versus $358.4-million a year earlier. Analysts were expecting sales of $427.7-million. Adjusted funds flow came in at $232.1-million or 42 cents versus $110.8-million or 20 cents a year earlier.